Surveillance perspective on Lyme borreliosis across the European Union and European Economic Area.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authorsvan den Wijngaard, Cees C
van Pelt, Wilfrid
Van Bortel, Wim
MetadataShow full item record
TitleSurveillance perspective on Lyme borreliosis across the European Union and European Economic Area.
Published inEuro Surveill 2017, 22(27): pii:30569
PubliekssamenvattingLyme borreliosis (LB) is the most prevalent tick-borne disease in Europe. Erythema migrans (EM), an early, localised skin rash, is its most common presentation. Dissemination of the bacteria can lead to more severe manifestations including skin, neurological, cardiac, musculoskeletal and ocular manifestations. Comparison of LB incidence rates in the European Union (EU)/European Economic Area (EEA) and Balkan countries are difficult in the absence of standardised surveillance and reporting procedures. We explored six surveillance scenarios for LB surveillance in the EU/EEA, based on the following key indicators: (i) erythema migrans, (ii) neuroborreliosis, (iii) all human LB manifestations, (iv) seroprevalence, (v) tick bites, and (vi) infected ticks and reservoir hosts. In our opinion, neuroborreliosis seems most feasible and useful as the standard key indicator, being one of the most frequent severe LB manifestations, with the possibility of a specific case definition. Additional surveillance with erythema migrans as key indicator would add value to the surveillance of neuroborreliosis and lead to a more complete picture of LB epidemiology in the EU/EEA. The other scenarios have less value as a basis for EU-level surveillance, but can be considered periodically and locally, as they could supply complementary insights.
- Combining primary care surveillance and a meta-analysis to estimate the incidence of the clinical manifestations of Lyme borreliosis in Belgium, 2015-2017.
- Authors: Geebelen L, Van Cauteren D, Devleesschauwer B, Moreels S, Tersago K, Van Oyen H, Speybroeck N, Lernout T
- Issue date: 2019 Apr
- Trends in surveillance data of human Lyme borreliosis from six federal states in eastern Germany, 2009-2012.
- Authors: Wilking H, Stark K
- Issue date: 2014 Apr
- Incidence of tick-bite in man in Aland Islands: reference to the spread of Lyme borreliosis.
- Authors: Wahlberg P
- Issue date: 1990
- Epidemiology of Lyme borreliosis through two surveillance systems: the national Sentinelles GP network and the national hospital discharge database, France, 2005 to 2016.
- Authors: Septfons A, Goronflot T, Jaulhac B, Roussel V, De Martino S, Guerreiro S, Launay T, Fournier L, De Valk H, Figoni J, Blanchon T, Couturier E
- Issue date: 2019 Mar
- Lyme disease in the United Kingdom.
- Authors: Dubrey SW, Bhatia A, Woodham S, Rakowicz W
- Issue date: 2014 Jan